vs
INVO Fertility, Inc.（IVF）与Lucid Diagnostics Inc.（LUCD）财务数据对比。点击上方公司名可切换其他公司
INVO Fertility, Inc.的季度营收约是Lucid Diagnostics Inc.的1.5倍（$1.8M vs $1.2M），INVO Fertility, Inc.净利率更高（-150.5% vs -858.5%，领先708.0%），INVO Fertility, Inc.同比增速更快（22.6% vs 3.3%），过去两年INVO Fertility, Inc.的营收复合增速更高（12.8% vs 7.9%）
INVO Fertility是一家专注于辅助生殖医疗解决方案的企业，核心产品为专利INVOcell阴道内培养装置，服务北美、欧洲等地区的生殖诊所与患者，致力于降低生育治疗门槛，为有需求的群体提供可负担的生殖医疗服务。
Lucid Diagnostics Inc.是一家处于商业化阶段的医疗诊断企业，专注于研发和推广上消化道疾病相关非侵入性筛查产品，核心覆盖食管癌及癌前病变早筛领域，主要为美国境内医疗机构及临床合作伙伴提供相关解决方案。
IVF vs LUCD — 直观对比
营收规模更大
IVF
是对方的1.5倍
$1.2M
营收增速更快
IVF
高出19.3%
3.3%
净利率更高
IVF
高出708.0%
-858.5%
两年增速更快
IVF
近两年复合增速
7.9%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8M | $1.2M |
| 净利润 | $-2.6M | $-10.4M |
| 毛利率 | — | — |
| 营业利润率 | -93.1% | -971.0% |
| 净利率 | -150.5% | -858.5% |
| 营收同比 | 22.6% | 3.3% |
| 净利润同比 | -62.2% | 16.0% |
| 每股收益（稀释后） | $-0.77 | $-0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVFLUCD
| Q3 25 | $1.8M | $1.2M | ||
| Q2 25 | $1.9M | $1.2M | ||
| Q1 25 | $1.6M | $828.0K | ||
| Q4 24 | $1.7M | $1.2M | ||
| Q3 24 | $1.4M | $1.2M | ||
| Q2 24 | $1.8M | $976.0K | ||
| Q1 24 | $1.6M | $1.0M | ||
| Q4 23 | $1.4M | $1.0M |
净利润IVFLUCD
| Q3 25 | $-2.6M | $-10.4M | ||
| Q2 25 | $-5.3M | $-4.4M | ||
| Q1 25 | $-17.4M | $-26.9M | ||
| Q4 24 | $-3.6M | $-11.5M | ||
| Q3 24 | $-1.6M | $-12.4M | ||
| Q2 24 | $-2.2M | $-11.0M | ||
| Q1 24 | $-1.6M | $-10.6M | ||
| Q4 23 | $-2.0M | $-10.8M |
毛利率IVFLUCD
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 31.0% | — | ||
| Q2 24 | 53.1% | — | ||
| Q1 24 | 45.3% | — | ||
| Q4 23 | 33.0% | — |
营业利润率IVFLUCD
| Q3 25 | -93.1% | -971.0% | ||
| Q2 25 | -160.4% | -978.8% | ||
| Q1 25 | -1042.1% | -1508.1% | ||
| Q4 24 | -202.0% | -1033.8% | ||
| Q3 24 | -90.7% | -997.8% | ||
| Q2 24 | -100.9% | -1146.7% | ||
| Q1 24 | -95.7% | -1078.1% | ||
| Q4 23 | -109.2% | -1101.3% |
净利率IVFLUCD
| Q3 25 | -150.5% | -858.5% | ||
| Q2 25 | -283.6% | -381.7% | ||
| Q1 25 | -1060.1% | -3249.8% | ||
| Q4 24 | -211.3% | -964.2% | ||
| Q3 24 | -113.8% | -1055.5% | ||
| Q2 24 | -122.2% | -1127.6% | ||
| Q1 24 | -101.3% | -1060.1% | ||
| Q4 23 | -144.4% | -1041.3% |
每股收益（稀释后）IVFLUCD
| Q3 25 | $-0.77 | $-0.10 | ||
| Q2 25 | $-13.30 | $-0.08 | ||
| Q1 25 | $-12.53 | $-0.52 | ||
| Q4 24 | $14.86 | $-0.17 | ||
| Q3 24 | $-15.11 | $-0.25 | ||
| Q2 24 | $-22.39 | $-0.23 | ||
| Q1 24 | $-7.55 | $-0.40 | ||
| Q4 23 | $-59.51 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $47.3M |
| 总债务越低越好 | $2.0M | — |
| 股东权益账面价值 | $5.8M | $25.8M |
| 总资产 | $18.8M | $53.2M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资IVFLUCD
| Q3 25 | — | $47.3M | ||
| Q2 25 | — | $31.1M | ||
| Q1 25 | — | $25.2M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | — | $24.9M | ||
| Q1 24 | — | $24.8M | ||
| Q4 23 | — | $18.9M |
总债务IVFLUCD
| Q3 25 | $2.0M | — | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $7.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
股东权益IVFLUCD
| Q3 25 | $5.8M | $25.8M | ||
| Q2 25 | $2.6M | $7.9M | ||
| Q1 25 | $3.3M | $-5.4M | ||
| Q4 24 | $12.7M | $5.4M | ||
| Q3 24 | $-23.3K | $6.3M | ||
| Q2 24 | $1.4M | $16.0M | ||
| Q1 24 | $10.2K | $11.9M | ||
| Q4 23 | $892.8K | $-2.3M |
总资产IVFLUCD
| Q3 25 | $18.8M | $53.2M | ||
| Q2 25 | $19.3M | $38.7M | ||
| Q1 25 | $31.7M | $32.8M | ||
| Q4 24 | $46.4M | $30.7M | ||
| Q3 24 | $17.0M | $22.6M | ||
| Q2 24 | $17.8M | $34.1M | ||
| Q1 24 | $17.3M | $32.0M | ||
| Q4 23 | $18.5M | $27.3M |
负债/权益比IVFLUCD
| Q3 25 | 0.34× | — | ||
| Q2 25 | 1.83× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.8M | $-10.9M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -101.6% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.8M | — |
8季度趋势，按日历期对齐
经营现金流IVFLUCD
| Q3 25 | $-1.8M | $-10.9M | ||
| Q2 25 | $-1.7M | $-10.5M | ||
| Q1 25 | $-3.5M | $-12.5M | ||
| Q4 24 | $-617.4K | $-9.9M | ||
| Q3 24 | $-640.8K | $-10.2M | ||
| Q2 24 | $-1.5M | $-11.5M | ||
| Q1 24 | $-260.6K | $-12.6M | ||
| Q4 23 | $-714.9K | $-10.0M |
自由现金流IVFLUCD
| Q3 25 | $-1.8M | — | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $-696.3K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.5M | — | ||
| Q1 24 | $-310.3K | — | ||
| Q4 23 | — | — |
自由现金流率IVFLUCD
| Q3 25 | -101.6% | — | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | -216.9% | — | ||
| Q4 24 | -40.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -82.3% | — | ||
| Q1 24 | -19.7% | — | ||
| Q4 23 | — | — |
资本支出强度IVFLUCD
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 3.2% | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
